{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:50Z","timestamp":1792785950993,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI109711"],"award-info":[{"award-number":["U19 AI109711"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI109762"],"award-info":[{"award-number":["U19 AI109762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HDTRA1-13-1-0034"],"award-info":[{"award-number":["HDTRA1-13-1-0034"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["HHSN272201400058C"],"award-info":[{"award-number":["HHSN272201400058C"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["5UC7AI094660-07"],"award-info":[{"award-number":["5UC7AI094660-07"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Animal Resource Center of the Galveston National Laboratory"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,22]]},"DOI":"10.1093\/infdis\/jiy295","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T07:09:30Z","timestamp":1529651370000},"page":"S565-S573","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates"],"prefix":"10.1093","volume":"218","author":[{"given":"Pavlo","family":"Gilchuk","sequence":"first","affiliation":[{"name":"Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad E","family":"Mire","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N","family":"Agans","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Deer","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Cross","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-1079","authenticated-orcid":false,"given":"James C","family":"Slaughter","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I","family":"Flyak","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Mani","sequence":"additional","affiliation":[{"name":"Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Pauly","sequence":"additional","affiliation":[{"name":"Mapp Biopharmaceutical, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Velasco","sequence":"additional","affiliation":[{"name":"Mapp Biopharmaceutical, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Whaley","sequence":"additional","affiliation":[{"name":"Mapp Biopharmaceutical, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Zeitlin","sequence":"additional","affiliation":[{"name":"Mapp Biopharmaceutical, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch, Galveston"},{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James E","family":"Crowe","sequence":"additional","affiliation":[{"name":"Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"key\n\t\t\t\t2018112203575122900_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rstb.2016.0297","article-title":"The Ebola outbreak, 2013\u20132016: old lessons for new epidemics","volume":"372","author":"Coltart","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0002","volume-title":"2016 Ebola virus disease fact sheet","author":"World Health Organization","year":"2017"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0004","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A randomized, controlled trial of ZMapp for Ebola virus infection","volume":"375","author":"Davey","year":"2016","journal-title":"N Eng J Med"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0005","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0006","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0007","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural Ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0008","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","edition":"8"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0009","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0010","doi-asserted-by":"crossref","first-page":"e2600","DOI":"10.1371\/journal.pntd.0002600","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo Ebolavirus","volume":"7","author":"Mire","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0011","volume-title":"Exact unconditional homogeneity\/independence tests for 2"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0012","first-page":"171","article-title":"Nonhuman primate models of Ebola virus disease","volume":"411","author":"Bennett","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fmicb.2013.00267","article-title":"Animal models for Ebola and Marburg virus infections","volume":"4","author":"Nakayama","year":"2013","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0014","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0015","doi-asserted-by":"crossref","first-page":"e02154","DOI":"10.1128\/mBio.02154-15","article-title":"Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies","volume":"7","author":"Bornholdt","year":"2016","journal-title":"MBio"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0016","doi-asserted-by":"crossref","first-page":"20514","DOI":"10.1038\/srep20514","article-title":"Discovery of an antibody for pan-ebolavirus therapy","volume":"6","author":"Furuyama","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0017","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.celrep.2016.04.026","article-title":"Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site","volume":"15","author":"Howell","year":"2016","journal-title":"Cell Rep"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0018","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/JVI.02172-15","article-title":"Macaque monoclonal antibodies targeting novel conserved epitopes within Filovirus glycoprotein","volume":"90","author":"Keck","year":"2016","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0019","doi-asserted-by":"crossref","first-page":"16128","DOI":"10.1038\/nmicrobiol.2016.128","article-title":"Structures of Ebola virus GP and sGP in complex with therapeutic antibodies","volume":"1","author":"Pallesen","year":"2016","journal-title":"Nat Microbiol"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2017.04.038","article-title":"Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability","volume":"169","author":"Zhao","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0021","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","article-title":"Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses","volume":"169","author":"Wec","year":"2017","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-018-0157-z","article-title":"Neutralizing antibodies from human survivors target a conserved site in the Ebolavirus glycoprotein HR2\/MPER region","author":"Flyak","year":"2018","journal-title":"Nat Microbiol"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0023","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.aag3267","article-title":"A \u201cTrojan horse\u201d bispecific-antibody strategy for broad protection against ebolaviruses","volume":"354","author":"Wec","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0024","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1128\/JVI.01033-16","article-title":"Ferrets infected with Bundibugyo virus or Ebola virus recapitulate important aspects of human filovirus disease","volume":"90","author":"Kozak","year":"2016","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8711","article-title":"Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody","volume":"9","author":"Mire","year":"2017","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0026","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","article-title":"Structural basis for Marburg virus neutralization by a cross-reactive human antibody","volume":"160","author":"Hashiguchi","year":"2015","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0027","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.cell.2015.01.031","article-title":"Mechanism of human antibody-mediated neutralization of Marburg virus","volume":"160","author":"Flyak","year":"2015","journal-title":"Cell"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0028","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/13543784.2016.1240785","article-title":"Monoclonal antibodies for the treatment of Ebola virus disease","volume":"25","author":"Moekotte","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0029","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1073\/pnas.93.8.3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0030","doi-asserted-by":"crossref","first-page":"e1003065","DOI":"10.1371\/journal.ppat.1003065","article-title":"Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus","volume":"8","author":"Mohan","year":"2012","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0031","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.molmed.2017.06.008","article-title":"Neutralizing the threat: Pan-Ebolavirus antibodies close the loop","volume":"23","author":"Mire","year":"2017","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0032","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.tim.2016.05.008","article-title":"Feverish quest for Ebola immunotherapy: straight or cocktail","volume":"24","author":"Saphire","year":"2016","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t2018112203575122900_CIT0033","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2017.05.008","article-title":"Ebolavirus\u2019s foibles","volume":"169","author":"Yamayoshi","year":"2017","journal-title":"Cell"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/suppl_5\/S565\/26688909\/jiy295.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T17:34:54Z","timestamp":1571506494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/suppl_5\/S565\/5049157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":33,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2018,7,5]]},"published-print":{"date-parts":[[2018,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy295","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,7,5]]}}}